Field evaluation of vaccine efficacy.
作者信息
Orenstein W A, Bernier R H, Dondero T J, Hinman A R, Marks J S, Bart K J, Sirotkin B
出版信息
Bull World Health Organ. 1985;63(6):1055-68.
Abstract
摘要
相似文献
1
Field evaluation of vaccine efficacy.
Bull World Health Organ. 1985;63(6):1055-68.
2
Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
Commun Dis Intell Q Rep. 2008 Jun;32 Suppl:S2-67.
3
Measles in Brazil.
EPI Newsl. 1984 Jun;6(3):1-3.
4
Evaluation of a measles vaccine efficacy during a measles outbreak in Mbare, City of Harare Zimbabwe.
Cent Afr J Med. 1997 Sep;43(9):254-6.
5
Effectiveness of Rubella vaccine in a rubella outbreak in Guangzhou city, China, 2014.
Vaccine. 2015 Jun 22;33(28):3223-7. doi: 10.1016/j.vaccine.2015.04.083. Epub 2015 May 16.
6
Famine-affected, refugee, and displaced populations: recommendations for public health issues.
MMWR Recomm Rep. 1992 Jul 24;41(RR-13):1-76.
7
One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
Pediatrics. 2006 Jun;117(6):e1070-7. doi: 10.1542/peds.2005-2085.
8
Expanded programme on immunization (EPI). Safety of high titre measles vaccines.
Wkly Epidemiol Rec. 1992 Nov 27;67(48):357-61.
9
A low-cost, community-based measles outbreak investigation with follow-up action.
Bull World Health Organ. 1992;70(3):317-21.
10
Measles vaccine efficacy in India: a review.
J Commun Dis. 1997 Mar;29(1):47-56.
引用本文的文献
1
Estimated Burden of Influenza and Direct and Indirect Benefits of Influenza Vaccination.
JAMA Netw Open. 2025 Jul 1;8(7):e2521324. doi: 10.1001/jamanetworkopen.2025.21324.
2
Socio-Demographic and Psychological Determinants of COVID-19 Vaccination Intention in Europe and North America: A Systematic Review.
Port J Public Health. 2025 May 26. doi: 10.1159/000546311.
3
A hybrid approach based on ELECTRE III-genetic algorithm and TOPSIS method for selection of optimal COVID-19 vaccines.
J Multi Criteria Decis Anal. 2022 Jan-Apr;29(1-2):80-91. doi: 10.1002/mcda.1772. Epub 2021 Nov 15.
4
Prediction of subnational-level vaccination coverage estimates using routine surveillance data and survey data.
Vaccine. 2025 Jul 11;60:127277. doi: 10.1016/j.vaccine.2025.127277. Epub 2025 May 27.
5
Quantitative risk assessment and interventional recommendations for preventing canine distemper virus infection in captive tigers at selected wildlife stations in Thailand.
PLoS One. 2025 Apr 17;20(4):e0320657. doi: 10.1371/journal.pone.0320657. eCollection 2025.
6
Immunogenicity and protective efficacy of seven candidate vaccines boosted with recombinant proteins, whole-cell bacterins of three serotypes of and an emulsion-type adjuvant.
Front Vet Sci. 2025 Mar 28;12:1553396. doi: 10.3389/fvets.2025.1553396. eCollection 2025.
7
Measles vaccine effectiveness in African children: a systematic review and meta-analysis.
BMC Infect Dis. 2024 Nov 21;24(1):1330. doi: 10.1186/s12879-024-10239-w.
8
Effectiveness of the Bivalent mRNA COVID-19 Vaccine for Preventing Critical Infection From the SARS-CoV-2 Omicron Variant in the Republic of Korea.
J Korean Med Sci. 2024 Sep 30;39(37):e258. doi: 10.3346/jkms.2024.39.e258.
9
Varicella vaccine effectiveness evaluation in Wuxi, China: A retrospective cohort study.
Epidemiol Infect. 2024 Sep 30;152:e105. doi: 10.1017/S095026882400102X.
10
Enhancement of clinical signs in C3H/HeJ mice vaccinated with a highly immunogenic Leptospira methyl-accepting chemotaxis protein following challenge.
PLoS Negl Trop Dis. 2024 Sep 23;18(9):e0012155. doi: 10.1371/journal.pntd.0012155. eCollection 2024 Sep.
本文引用的文献
1
Measles in Detroit, 1935 -I, Factors Influencing the Secondary Attack Rate Among Susceptibles at Risk.
Am J Public Health Nations Health. 1938 Aug;28(8):935-43. doi: 10.2105/ajph.28.8.935.
2
Infectiousness of communicable diseases in the household (measles, chickenpox, and mumps).
Lancet. 1952 Sep 20;2(6734):549-54. doi: 10.1016/s0140-6736(52)91357-3.
3
Epidemiology of pertussis, Atlanta, 1977.
J Pediatr. 1981 Mar;98(3):362-7. doi: 10.1016/s0022-3476(81)80696-8.
4
Measles and measles vaccine efficacy in a remote island population.
Bull World Health Organ. 1982;60(5):767-75.
5
Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method.
Bull World Health Organ. 1982;60(2):253-60.
6
Clinical efficacy of rubella vaccine.
Pediatr Infect Dis. 1983 Jul-Aug;2(4):284-6. doi: 10.1097/00006454-198307000-00005.
7
Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies.
Int J Epidemiol. 1984 Mar;13(1):87-93. doi: 10.1093/ije/13.1.87.
8
Estimators of relative risk for case-control studies.
Am J Epidemiol. 1983 Sep;118(3):396-407. doi: 10.1093/oxfordjournals.aje.a113646.
9
Measles mortality and vaccine efficacy in rural West Africa.
Lancet. 1983 Apr 30;1(8331):972-5. doi: 10.1016/s0140-6736(83)92091-3.
10
Measles vaccine: immunity, reinfection and revaccination.
Am J Epidemiol. 1973 Jun;97(6):365-71. doi: 10.1093/oxfordjournals.aje.a121517.
Zotero 插件